The Traderszone Network

Published in TZ Latest News 7 November, 2017 by The TZ Newswire Staff

Why Inovio Pharmaceuticals Stock Sank in October

According to S&P Global Market Intelligence, shares of the DNA vaccine maker Inovio Pharmaceuticals (NASDAQ: INO) shed 8% of their value last month. On the bright side, this high single-digit decline wasn’t the result of a negative clinical or regulatory event specific to the company.

read more